Leflunomide increases the risk of silent liver fibrosis in patients with rheumatoid arthritis receiving methotrexate

Evaluation of liver fibrosis by transient elastography (Fibroscan®) in patients with inflammatory bowel disease treated with methotrexate: a multicentric trial

(2012) A Barbero-Villares et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Update 2011: leflunomide in rheumatoid arthritis – strengths and weaknesses

(2011) Frank Behrens et al.   CURRENT OPINION IN RHEUMATOLOGY

Liver stiffness correlates with methotrexate cumulative dose in patients with rheumatoid arthritis

(2011) Umberto Arena et al.   DIGESTIVE AND LIVER DISEASE

Factors that affect the diagnostic accuracy of liver fibrosis measurement by Fibroscan in patients with chronic hepatitis B

(2010) S. U. Kim et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan)

(2010) Kyu Sik Jung et al.   HEPATOLOGY

Assessment of liver fibrosis by transient elastography in rheumatoid arthritis patients treated with methotrexate

(2010) Sung-Hoon Park et al.   JOINT BONE SPINE

Benefit-Risk Assessment of Leflunomide

(2009) Nicola Alcorn et al.   DRUG SAFETY

What are ‘true normal’ liver stiffness values using FibroScan®?: a prospective study in healthy living liver and kidney donors in South Korea

(2009) Seung Up Kim et al.   LIVER INTERNATIONAL

Efficacy and toxicity of methotrexate (MTX) monotherapy versus MTX combination therapy with non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and meta-analysis

(2008) W Katchamart et al.   ANNALS OF THE RHEUMATIC DISEASES

Performance of Transient Elastography for the Staging of Liver Fibrosis: A Meta-Analysis

(2008) Mireen Friedrich–Rust et al.   GASTROENTEROLOGY